• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌切除术后的长期结果。二十年个人经验。

Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience.

作者信息

Lygidakis N J, Sgourakis G J, Dedemadi G V, Vlachos L, Safioleas M

机构信息

Department of Surgical Oncology, Athens Medical Center, Apollonion Hospital, Athens, Greece.

出版信息

Hepatogastroenterology. 2001 Jan-Feb;48(37):95-101.

PMID:11269010
Abstract

BACKGROUND/AIMS: The purpose of this study was to assess whether long-term survival in patients suffering from cholangiocarcinomas of the porta hepatis is significantly different when comparing results between local and extended procedures in order to justify increased mortality and morbidity following extensive resections.

METHODOLOGY

From November 1991 to May 2000, 46 patients with Klatskin tumor were assigned to two groups. Group A patients (n = 25) had local resection and group B patients (n = 21) had local resection plus hemihepatectomy. On admission, all patients were drained via percutaneous transhepatic biliary drainage. In all patients we proceeded with an internal biliary drainage in order to anticipate jaundice and decompensated liver function. Internal biliary drainage was carried out 35-40 days before surgery. At the end of the operation an arterial catheter was introduced into the common hepatic artery for adjuvant locoregional targeting immunochemotherapy, which was initiated 20 days following surgery in all patients.

RESULTS

Overall survival for group A patients ranged from 14 months to 76 months (mean: 29). Disease-free survival ranged from 10-52 months (mean: 25). Five-year survival rate was 10%. Five-year disease-free survival was 0%. Overall survival for group B patients ranged from 28 months to 79 months (mean: 39). Disease-free survival ranged from 17-72 months (mean: 32). Five-year survival rate was 20%. Five-year disease-free survival rate was 10%.

CONCLUSIONS

Combined tumor and liver resection is associated with significantly better results when compared with those following tumor resection alone.

摘要

背景/目的:本研究旨在评估肝门部胆管癌患者接受局部手术与扩大手术的疗效,比较两者长期生存率是否存在显著差异,以论证扩大切除术增加的死亡率和发病率是否合理。

方法

1991年11月至2000年5月,46例Klatskin肿瘤患者被分为两组。A组患者(n = 25)接受局部切除术,B组患者(n = 21)接受局部切除加半肝切除术。入院时,所有患者均通过经皮肝穿胆道引流进行引流。为预防黄疸和肝功能失代偿,所有患者均进行了内引流。内引流在手术前35 - 40天进行。手术结束时,将动脉导管插入肝总动脉进行辅助局部靶向免疫化疗,所有患者在术后20天开始化疗。

结果

A组患者的总生存期为14个月至76个月(平均:29个月)。无病生存期为10 - 52个月(平均:25个月)。5年生存率为10%。5年无病生存率为0%。B组患者的总生存期为28个月至79个月(平均:39个月)。无病生存期为17 - 72个月(平均:32个月)。5年生存率为20%。5年无病生存率为10%。

结论

与单纯肿瘤切除相比,联合肿瘤和肝脏切除的疗效显著更好。

相似文献

1
Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience.肝门部胆管癌切除术后的长期结果。二十年个人经验。
Hepatogastroenterology. 2001 Jan-Feb;48(37):95-101.
2
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
3
Diagnostic and surgical features of Klatskin tumors.肝门部胆管癌的诊断与手术特征。
Chir Ital. 1999 Jan-Feb;51(1):1-7.
4
Changing trends in the management of Klatskin tumor.肝门部胆管癌治疗的变化趋势
Hepatogastroenterology. 2004 May-Jun;51(57):689-96.
5
Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.肝门部胆管癌手术的进展显示预后改善:一项单中心分析
Tumori. 2014 Nov-Dec;100(6):e250-6. doi: 10.1700/1778.19288.
6
[Klatskin's tumors].
Ugeskr Laeger. 2005 Apr 4;167(14):1525-30.
7
[Surgical therapy of hilar cholangiocarcinoma].[肝门部胆管癌的外科治疗]
Chirurg. 2006 Apr;77(4):325-34. doi: 10.1007/s00104-006-1177-4.
8
[Surgical therapy of proximal extrahepatic bile duct tumors (Klatskin tumors)].肝外胆管近端肿瘤(克氏瘤)的外科治疗
Zentralbl Chir. 2007 Aug;132(4):328-35. doi: 10.1055/s-2007-981201.
9
[Surgical treatment of Klatskin's tumor].[肝门部胆管癌的外科治疗]
Rev Gastroenterol Peru. 1995 May-Aug;15(2):167-75.
10
Klatskin tumour: meticulous preoperative work-up and resection rate.肝门部胆管癌:细致的术前评估与切除率
Z Gastroenterol. 2011 Apr;49(4):436-42. doi: 10.1055/s-0029-1246011. Epub 2011 Apr 7.

引用本文的文献

1
Tumor markers as a diagnostic key for hilar cholangiocarcinoma.肿瘤标志物作为肝门部胆管癌的诊断关键。
Eur J Med Res. 2010 Aug 20;15(8):357-61. doi: 10.1186/2047-783x-15-8-357.
2
Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma.肝门部胆管癌患者的长期预后及预后因素
World J Gastroenterol. 2007 Mar 7;13(9):1422-6. doi: 10.3748/wjg.v13.i9.1422.
3
Cross-sectional imaging of biliary tumors: current clinical status and future developments.胆管肿瘤的横断面成像:当前临床现状与未来发展
Eur Radiol. 2004 Jul;14(7):1174-87. doi: 10.1007/s00330-004-2327-z. Epub 2004 Apr 23.